Novo Holdings Cyteir Therapeutics, Inc. (CYT) insider trading activity

CYT Quotes by TradingView

Novo Holdings is > 10% Shareholder of Cyteir Therapeutics, Inc.. Currently has a direct ownership of 3.52 Million shares of CYT, which is worth approximately $10.6 Million. The most recent transaction as insider was on Jul 20, 2023, when has been sold 100,000 shares (Common Stock) at a price of $2.75 per share, resulting in proceeds of $275,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.52M
0% 3M change
10.62% 12M change
Total Value Held $10.6 Million

Novo Holdings Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 20 2023
SELL
Open market or private sale
$275,000 $2.75 p/Share
100,000 Reduced 2.76%
3,522,136 Common Stock
Jul 19 2023
SELL
Open market or private sale
$5,244 $2.76 p/Share
1,900 Reduced 0.05%
3,622,136 Common Stock
Jul 18 2023
SELL
Open market or private sale
$17,940 $2.76 p/Share
6,500 Reduced 0.18%
3,624,036 Common Stock
Jul 17 2023
SELL
Open market or private sale
$58,025 $2.75 p/Share
21,100 Reduced 0.58%
3,630,536 Common Stock
Jul 14 2023
SELL
Open market or private sale
$30,140 $2.74 p/Share
11,000 Reduced 0.3%
3,651,636 Common Stock
Jun 30 2023
SELL
Open market or private sale
$528,464 $2.63 p/Share
200,937 Reduced 5.2%
3,662,636 Common Stock
Jun 27 2023
SELL
Open market or private sale
$56,601 $1.77 p/Share
31,978 Reduced 0.82%
3,863,573 Common Stock
Jun 26 2023
SELL
Open market or private sale
$15,102 $1.79 p/Share
8,437 Reduced 0.22%
3,895,551 Common Stock
Jun 23 2023
SELL
Open market or private sale
$6,435 $1.88 p/Share
3,423 Reduced 0.09%
3,903,988 Common Stock
Jun 22 2023
SELL
Open market or private sale
$9,779 $1.94 p/Share
5,041 Reduced 0.13%
3,907,411 Common Stock
Jun 21 2023
SELL
Open market or private sale
$9,619 $1.99 p/Share
4,834 Reduced 0.12%
3,912,452 Common Stock
Jun 20 2023
SELL
Open market or private sale
$1,569 $2.11 p/Share
744 Reduced 0.02%
3,917,286 Common Stock
Jun 16 2023
SELL
Open market or private sale
$12,145 $2.03 p/Share
5,983 Reduced 0.15%
3,918,030 Common Stock
Jun 15 2023
SELL
Open market or private sale
$20,304 $2.03 p/Share
10,002 Reduced 0.25%
3,924,013 Common Stock
Jun 14 2023
SELL
Open market or private sale
$6,059 $2.11 p/Share
2,872 Reduced 0.07%
3,934,015 Common Stock
Jun 13 2023
SELL
Open market or private sale
$5,514 $2.1 p/Share
2,626 Reduced 0.07%
3,936,887 Common Stock
Jun 12 2023
SELL
Open market or private sale
$1,854 $2.06 p/Share
900 Reduced 0.02%
3,939,513 Common Stock
Jul 20 2022
SELL
Open market or private sale
$2,700,000 $3.0 p/Share
900,000 Reduced 18.59%
3,940,413 Common Stock
Jun 22 2021
BUY
Open market or private purchase
$4,999,986 $18.0 p/Share
277,777 Added 5.43%
4,840,413 Common Stock
Jun 22 2021
BUY
Conversion of derivative security
-
4,562,636 Added 50.0%
4,562,636 Common Stock

Also insider at

HRMY
Harmony Biosciences Holdings, Inc. Healthcare
> 10% Shareholder
MORF
Morphic Holding, Inc. Healthcare
> 10% Shareholder
VERV
Verve Therapeutics, Inc. Healthcare
> 10% Shareholder
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
INGN
Inogen Inc Healthcare
> 10% Shareholder
NKTX
Nkarta, Inc. Healthcare
> 10% Shareholder
EWTX
Edgewise Therapeutics, Inc. Healthcare
> 10% Shareholder
KALV
KalVista Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
MIST
Milestone Pharmaceuticals Inc. Healthcare
> 10% Shareholder
IOBT
IO Biotech, Inc. Healthcare
PRAX
Praxis Precision Medicines, Inc. Healthcare
> 10% Shareholder
INZY
Inozyme Pharma, Inc. Healthcare
> 10% Shareholder
ETTX
Entasis Therapeutics Holdings Inc. Healthcare
> 10% Shareholder
GMTX
Gemini Therapeutics, Inc. Healthcare
> 10% Shareholder
BOLT
Bolt Biotherapeutics, Inc. Healthcare
> 10% Shareholder
UTRS
MINERVA SURGICAL INC Healthcare
> 10% Shareholder
RPHM
Reneo Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
ALGS
Aligos Therapeutics, Inc. Healthcare
> 10% Shareholder
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
GLTO
Galecto, Inc. Healthcare
> 10% Shareholder
SPRB
SPRUCE BIOSCIENCES, INC. Healthcare
> 10% Shareholder
GRTX
Galera Therapeutics, Inc. Healthcare
> 10% Shareholder
EAR
Eargo, Inc. Healthcare
> 10% Shareholder
ACLX
Arcellx, Inc. Healthcare
> 10% Shareholder
CMPI
Checkmate Pharmaceuticals, Inc.
> 10% Shareholder
MGX
Metagenomi, Inc.
> 10% Shareholder
NH

Novo Holdings

> 10% Shareholder
Hellerup, G7

Track Institutional and Insider Activities on CYT

Follow Cyteir Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYT shares.

Notify only if

Insider Trading

Get notified when an Cyteir Therapeutics, Inc. insider buys or sells CYT shares.

Notify only if

News

Receive news related to Cyteir Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYT